Glycan changes: cancer metastasis and anti-cancer vaccines

被引:0
作者
Min Li
Lujun Song
Xinyu Qin
机构
[1] Fudan University,Department of General Surgery, Zhongshan Hospital, Shanghai Medical School
来源
Journal of Biosciences | 2010年 / 35卷
关键词
Anti-cancer vaccines; cancer; glycan; glycosylation; metastatis; therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Complex carbohydrates, which are major components of the cell membrane, perform important functions in cell-cell and cell-extracellular matrix interactions, as well as in signal transduction. They comprise three kinds of biomolecules: glycoproteins, proteoglycans and glycosphingolipids. Recent studies have also shown that glycan changes in malignant cells take a variety of forms and mediate key pathophysiological events during the various stages of tumour progression. Glycosylation changes are universal hallmarks of malignant transformation and tumour progression in human cancer, which take place on the whole cells or some specific molecules. Accordingly, those changes make them prominent candidates for cancer biomarkers in the meantime. This review mainly focuses on the correlation between glycosylation and the metastasis potential of tumour cells from comprehensive aspects to further address the vital roles of glycans in oncogenesising. Moreover, utilizing these glycosylation changes to ward off tumour metastasis by means of anti-adhesion approach or devising anti-cancer vaccine is one of promising targets of future study.
引用
收藏
页码:665 / 673
页数:8
相关论文
共 476 条
[1]  
Ariga T.(2009)Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors Neurosignals 17 226-234
[2]  
Suetake K.(2008)Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation Proteomics 8 3284-3293
[3]  
Nakane M.(2008)The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymers Pharm. Res. 25 379-386
[4]  
Kubota M.(2003)Glycosphingolipids and cell death Glycoconjugate J. 20 39-47
[5]  
Usuki S.(2009)Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4(+) nd CD8(+) T cell epitopes Cancer Immunol. Immun. 58 187-200
[6]  
Kawashima I.(1999)Pathways of O-glycan biosynthesis in cancer cells Bba-Gen Subjects 1473 67-95
[7]  
Yu R. K.(2009)Immunotherapy for cancer: synthetic carbohydrate-based vaccines Chem. Commun. 36 5335-5349
[8]  
Arnold J. N.(2010)Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate J. Biotechnol. 146 74-83
[9]  
Saldova R.(2009)Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer Arch. Immunol. Ther. Ex. 57 409-423
[10]  
Hamid U.(2010)Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy Clin. Cancer Res. 16 3205-3214